Trilogy Capital’s Sanofi SNY Stock Holding History

Trilogy Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-66	Closed	-$3K	–	495
2018 Q3	$3K	Hold	66	–	–	﹤0.01%	466
2018 Q2	$3K	Hold	66	–	–	﹤0.01%	425
2018 Q1	$3K	Buy	+66	New	+$2.75K	﹤0.01%	359

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Trilogy Capital's SNY Position: Q4 2018 in Review

Trilogy Capital sold out of Sanofi (SNY) in Q4 2018, closing a stake of 66 shares — an estimated $3K sold.

Trilogy Capital first reported a position in SNY in Q1 2018 and held it in 3 quarters. The position peaked at $3K in Q3 2018. 501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.

Trilogy Capital reported no remaining Sanofi position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 66 Sanofi shares in Q4 2018, an estimated $3K.
Trilogy Capital first reported a position in Sanofi in Q1 2018 and held it in 3 quarters.
Trilogy Capital's Sanofi position peaked at $3K in Q3 2018.
501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.